Glaukos Announces Participation in Wells Fargo Healthcare Conference
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that its management is scheduled to participate in the Wells Fargo Healthcare Conference on Thursday, September 7, 2017, at 1:05 p.m. EDT in Boston, MA. A live audio webcast for this event will be available in the Investors section